Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5'-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I

Nagendra Prasad, Robert S. Topping and Stuart J. Decker*

Department of Cancer Molecular Sciences, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA

* Author for correspondence (e-mail: stuart.decker{at}pfizer.com)

Accepted 25 July 2002


    Summary
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Inositol phosphatases play an important role in regulation of cellular levels of lipid second messengers. Recently we have reported a novel function for SHIP2 in cell adhesion and spreading. In this study, we further characterize the adhesion-dependent tyrosine phosphorylation of SHIP2 and examine the role of Src family tyrosine kinases in the regulation of SHIP2 function. SHIP2 was tyrosine phosphorylated during cell attachment and spreading on collagen I, but not on fibronectin, collagen IV, laminin or poly-L-lysine. SHIP2 tyrosine phosphorylation, induced by plating on a collagen-I-coated surface but not by epidermal growth factor or insulin treatment of cells, was completely blocked by small molecule inhibitors of Src family kinases. SHIP2 could be phosphorylated in vitro by recombinant Src kinase and tyrosines 986-987 in the NPXY motif of SHIP2 appear to be the major sites of phosphorylation for Src both in vitro and in vivo. An activated form of Src induced strong tyrosine phosphorylation of SHIP2 while a dominant-negative form decreased collagen-I-dependent SHIP2 phosphorylation. SHIP2 associated with the adapter protein Shc via its NPXY motif during cell spreading on collagen I in a Src activity-dependent manner. Expression of SHIP2 with mutated NPXY motif caused deregulation of lamellipodia formation during spreading on collagen I. These observations indicate that SHIP2 is regulated by Src family kinases during cell attachment and spreading on collagen I and suggest an important role for SHIP2 as a part of a signaling pathway that regulates actin cytoskeleton remodeling.

Key words: 5' inositol phosphatase, SHIP2, Src kinase, Shc, Adhesion, Collagen I


    Introduction
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Metabolites of phosphatidylinositol (PtdIns) serve as important second messengers that regulate cellular signaling pathways. Among several cellular enzymes that specifically modify PtdIns, phosphoinositide 3-kinase (PI 3-kinase) is shown to be pivotal in growth factor, insulin and G protein-mediated signal transduction (Corvera and Czech, 1998Go). In addition, PI 3-kinase is implicated in the regulation of adhesion and migration (Jones et al., 2000Go). Specific inhibitors of PI 3-kinase inhibited adhesion and migration in a variety of cell types (Ji and Haimovich, 1999Go; King et al., 1997Go; Zheng et al., 2000Go). Activated PI 3-kinase localizes to cell-cell as well as cell-matrix adhesion sites in epithelial cells and to membrane ruffles in fibroblasts (Watton and Downward, 1999Go). Activation of Akt/PKB, a downstream target of the PI 3-kinase pathway occurs upon integrin ligation (Khwaja et al., 1997Go; King et al., 1997Go). The regulatory p85 subunit of PI 3-kinase interacts with proteins regulating adhesion and migration such as focal adhesion kinase (FAK), Src and p130Crk-associated substrate (p130Cas) (Bachelot et al., 1996Go; Fukui and Hanafusa, 1989Go; Li et al., 2000Go). Recruitment and activation of Src to the integrin-extracellular matrix (ECM) contacts occurs early in the adhesion process (Fincham et al., 1996Go). A number of these Src substrates, including p130Cas, paxillin, cortactin and talin, play a critical role in actin cytoskeleton rearrangements, cell spreading and migration (Jones et al., 2000Go; Schwartz, 2001Go).

Inositol phosphatases regulate the cellular levels of lipid second messengers (Majerus et al., 1999Go). A 3' inositol phosphatase PTEN/MMAC1 is frequently inactivated in tumor cells leading to increased PI 3-kinase product, phosphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] resulting in activation of Akt/PKB. PTEN also regulates integrin-mediated activation of extracellular signal regulated kinase (ERK), interacts with FAK and inhibits adhesion, migration and invasion processes (Di Cristofano and Pandolfi, 2000Go). The 5' inositol phosphatases, SH2-containing inositol 5-phosphatase 1 and 2 (SHIP1 and SHIP2) specifically dephosphorylate PtdIns(3,4,5)P3, and inositol (1,3,4,5)-tetrakiphosphate [Ins(1,3,4,5)P4] on the D5 position of the inositol ring (Erneux et al., 1998Go). While SHIP1 expression is restricted primarily to hematopoietic tissues, SHIP2 appears to be ubiquitous (Habib et al., 1998Go; Rohrschneider et al., 2000Go). Analogous to the negative regulation of growth factor and antigen receptor-mediated signaling by SHIP1, some studies suggest that SHIP2 downregulates insulin and Fc{gamma}RIIB receptor signaling (Muraille et al., 1999Go; Wada et al., 2001Go). Targeted deletion of SHIP2 in mice produced neonatal fatality attributed to hypoglycemia and insulin hypersensitivity (Clement et al., 2001Go). Overexpressed SHIP2 downregulated Akt activation and caused cell-cycle arrest (Taylor et al., 2000Go). In addition, the same group reported that SHIP2 effectively utilizes phosphatidylinositol (4,5)-biphosphate [PtdIns(4,5)P2] as its substrate in addition to already reported PtdIns(3,4,5)P3 and Ins(1,3,4,5)P4 (Taylor et al., 2000Go).

Besides an N-terminal SH2 domain, both SHIP1 and SHIP2 possess proline-rich regions and NPXY motifs (two in SHIP1 and one in SHIP2) serving as potential protein-protein interaction sites (Rohrschneider et al., 2000Go). SHIP2 also has a C-terminal SAM domain that is not present in SHIP1. Recently we reported that an important regulator of adhesion and migration processes, p130Cas, interacted with the SH2 domain of SHIP2 (Prasad et al., 2001Go). In HeLa cells, SHIP2 localized to focal contacts during attachment and to lamellipodia in spreading cells. Wild-type SHIP2 promoted adhesion while catalytically inactive SHIP2 inhibited spreading of HeLa cells. In this report, we further characterize the involvement of SHIP2 in adhesion providing evidence that SHIP2 tyrosine phosphorylation specifically occurs during cell attachment and spreading on collagen I, and that phosphorylation is mediated through activation of Src family kinases.


    Materials and Methods
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
Anti-FLAG (M2) monoclonal antibody, a rabbit polyclonal anti-FLAG antibody, rat-tail collagen I, collagen IV, laminin, poly-L-lysine, phalloidin-TRITC were from Sigma Chemicals. Collagen I (rat tail) was also purchased from Roche Biochemicals. Anti-phosphotyrosine (clone 4G10) and anti-Src (clone GD11) antibodies were from Upstate Biotech. Monoclonal anti-Shc and rabbit polyclonal anti-Shc antibodies were obtained from Transduction Labs. We obtained horseradish peroxidase (HRP)-conjugated anti-mouse IgG and anti-rabbit IgG-HRP from NEB. Oregon Green-conjugated anti-mouse IgG was from Molecular Probes. Rabbit polyclonal anti-SHIP2 antiserum was raised as described earlier (Habib et al., 1998Go). Expression vectors for activated Src and dominant-negative Src in pUSE.amp were purchased from Upstate Biotech.

Cell culture
HeLa, SH-SY5Y, Madin Darby canine kidney (MDCK) and 293T cells were routinely cultured in DMEM (with high glucose, pyridoxine hydrochloride, l-glutamine and without sodium pyruvate) containing 10% FBS. Culturing and induction of differentiation of 3T3-L1 adipocytes was done as described previously (Habib et al., 1998Go). Transient transfections of HeLa cells were carried out using Lipofectamine-Plus reagent (Invitrogen) according to the manufacturer's instructions. Briefly, cells were cultured in 60 mm dishes 18-20 hours before transfection to obtain 30-40% confluency at the time of transfection. 2 µg DNA, 5 µl Plus reagent and 8 µl lipofectamine were used per 60 mm dish. Transfections were carried out for 5 hours at 37°C. Experiments were carried out 48 hours post-transfection. For cells cultured in 100 mm dishes, 7.5 µg DNA, 15 µl `Plus' reagent and 25 µl lipofectamine were used. 293T cells were transfected by a modified CaPO4 method (Stratagene).

Construction of expression vectors encoding epitope-tagged SHIP2
cDNAs encoding full length SHIP2 with a FLAG epitope at the C-terminus (SHIP2-FLAG) were cloned into the pcDNA3 mammalian expression vector. Site-directed mutagenesis was used to replace the tyrosines with phenylalanines. These constructs were tagged with the FLAG epitope at the C-terminus.

Procedure for coating polystyrene (bacterial) petri dishes
Rat-tail collagen I was resuspended in 0.1 M acetic acid to 1 mg/ml concentration with stirring for 1-3 hours at room temperature (RT). Collagen I solution was stored at 4°C and pre-warmed to 37°C prior to coating. Non-tissue culture treated (bacterial) polystyrene plates were coated in phosphate buffered saline (PBS, 4.0 ml per dish) containing collagen I at indicated concentrations with lids open in the laminar-flow hood for 1 hour. Excess collagen solution was removed, washed twice with PBS and blocked in PBS containing 1% bovine serum albumin (BSA) in the hood with lids open for 30 minutes. Plates were washed twice more with PBS prior to usage. Coating of dishes with fibronectin (5 µg/cm2), collagen IV (6 µg/cm2), laminin (2 µg/cm2) and poly-L-lysine (0.01% solution, 0.5 ml/25 cm2) was carried out similarly.

Immunoprecipitation and western blot analyses
HeLa cells cultured under various conditions were processed as follows. For adherent (Ad) samples, confluent cells in 100 mm tissue dishes were serum starved for 3 hours in DMEM containing 0.5% BSA, washed once with cold PBS and scraped in HNTG lysis buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM EGTA, 1 mM EDTA, 10 mM sodium pyrophosphate, 100 mM sodium fluoride, 0.2 mM sodium orthovanadate, 1 mM PMSF and protease inhibitor cocktail from Boehringer Mannheim). Detached cell lysates (D) were prepared as follows. Cell monolayers were treated with 1x trypsin-EDTA (Invitrogen) for 3 minutes. Trypsin was inactivated by soybean trypsin inhibitor (1 mg/ml in DMEM containing 0.25% BSA). Cells were then centrifuged for 3 minutes at 50 g in a tabletop centrifuge and washed once with PBS prior to lysis in HNTG buffer. For samples from re-attaching cells, serum starved cells detached as above were re-plated in DMEM/0.5% BSA for indicated intervals on bacterial petri dishes coated with either collagen I or other attachment factors as indicated. At the indicated intervals, cells were gently washed once with cold PBS and adherent cells were scraped in HNTG lysis buffer. Medium and the PBS wash containing non-adherent cells (if any) were centrifuged and the resulting cell pellet was combined with the lysate from adherent cells. Immunoprecipitations from equal amounts of proteins and western blots were carried out as described previously (Prasad et al., 2000Go). For SHIP2-Shc co-immunoprecipitation experiments (shown in Fig. 8), NP-40 lysis buffer (20 mM Tris-HCl, pH 7.5, 1% NP-40, 10% glycerol, 25 mM NaCl, 1 mM PMSF, 1 mM EGTA, 1 mM EDTA, 0.2 mM sodium orthovanadate and protease inhibitor cocktail from Boehringer Mannheim) was used. After immunoprecipitations with the indicated antibodies and protein A/G agarose, immune complexes were washed three times with NP-40 wash buffer (the same as NP-40 lysis buffer but containing 75 mM NaCl). Samples were then boiled with SDS-sample buffer prior to electrophoresis.



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 8. SHIP2 associates with Shc via the NPXY motif. (A) Anti-SHIP2 or control (Pre) IPs from HeLa cells that were detached (D) or replated for 60 minutes on collagen I (6 µg/cm2; C.I) were blotted with anti-Shc (monoclonal) or anti-SHIP2 antibodies. (B) Anti-SHIP2 or control (Pre) IPs, from HeLa cells that were re-plated for 60 minutes on collagen I (6 µg/cm2; C.I), fibronectin (5 µg/cm2; F), or poly-L-lysine (0.01% solution, 0.5 ml/25 cm2; P-Ly) were blotted with anti-Shc (monoclonal) or anti-SHIP2 antibodies as indicated. Cells were plated in the presence of vehicle control DMSO (-) or 1 µM Src inhibitor compound PD180970 (+). Whole cell lysate was used as a control (WCL). (C) HeLa cells were transiently transfected with wild-type or YY-FF (986-987) mutant SHIP2 expression constructs. 48 hours post-transfection, serum-starved cells were re-plated on collagen I (6 µg/cm2) for 60 minutes. Anti-FLAG (rabbit polyclonal) IPs from these samples were blotted with anti-Shc (monoclonal) or monoclonal anti-FLAG (M2) antibodies. Whole cell lysate was used as a control (WCL). (D) Anti-Shc (monoclonal) or control mouse IgG (MIg) IPs from HeLa cells re-plated for 60 minutes on collagen I (6 µg/cm2; C.I), fibronectin (5 µg/cm2; F), or poly-L-lysine (0.01% solution, 0.5 ml/25 cm2; P-Ly) were blotted with anti-SHIP2 or anti-Shc (polyclonal) antibodies as indicated. Cells were plated in the presence of either vehicle control DMSO (-) or 1 µM Src inhibitor compound PD180970 (+). Whole cell lysate was used as a control (WCL). Small arrows point to the three forms of Shc proteins. The large arrowhead points to SHIP2 protein.

 

In vitro phosphorylation assays
FLAG-tagged wild-type SHIP2 or YY-FF (986-987) mutant proteins were expressed in 293T cells by transient transfection. 48 hours post-transfection, cells were lysed in HNTG buffer and FLAG-tagged proteins were purified using anti-FLAG (M2) antibody and protein A/G plus agarose. Purified wild-type and YY-FF mutant SHIP2 bound to protein A/G beads, were washed once with kinase assay buffer (10 mM Hepes pH 7.5, 10 mM MgCl2, 10 mM MnCl2, 1 mM DTT, 1 mM EGTA and 0.1 mM sodium orthovanadate) and resuspended in assay buffer. Beads were then incubated with 5 units of recombinant Src kinase (Upstate Biotech) and 200 µM ATP for 10 minutes at 30°C. Reactions were stopped by adding ice-cold assay buffer. Beads were washed twice with assay buffer and resuspended in SDS-sample buffer. SDS-PAGE and western analyses of the samples were carried out as described above.

Immunofluorescence staining
HeLa cells, cultured in 12-well dishes, were transiently transfected with expression constructs of FLAG-tagged wild-type SHIP2 or YY-FF (986-987) mutant expression constructs. 48 hour post-transfection, cells were trypsinized and re-plated for 1 hour on chamber slides coated with collagen I (6 µg/cm2 for 1 hour) or fibronectin (5 µg/cm2 for 1 hour) followed by anti-FLAG (M2) immunofluorescence staining as previously described (Prasad et al., 2001Go). Prior to the final washes, cells were counterstained with phalloidin-TRITC (1 µg/ml) for 15 minutes. Finally, cells were washed five times in PBS followed by confocal microscopy.


    Results
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cell attachment on collagen I induces SHIP2 tyrosine phosphorylation
Previously we have observed adhesion-dependent tyrosine phosphorylation of SHIP2 in HeLa cells (Prasad et al., 2001Go). We wished to determine whether such a modification occurs in response to adhesion of cells to specific extracellular matrix proteins. When serum-starved HeLa cells were detached from tissue-culture-treated plastic by trypsinization, background levels of SHIP2 tyrosine phosphorylation were abolished as observed earlier. Re-plating of cells on a collagen-I-coated non-tissue-culture-treated polystyrene surface induced robust tyrosine phosphorylation of SHIP2 as observed by an anti-phosphotyrosine blot of anti-SHIP2 immunoprecipitates (Fig. 1A). SHIP2 phosphorylation appeared 30 minutes postplating, was highest by 60 minutes and was persistent for up to 20 hours (data not shown). Two co-precipitating tyrosine-phosphorylated protein species (~180 kDa and 200-220 kDa) were appared under such conditions. The identity of these SHIP2-associated proteins remains unknown. Our efforts to identify these proteins using specific antibodies against candidate proteins such as p190RhoGAP, talin, tensin and integrin ß4 were unsuccessful (data not shown). The induction of SHIP2 tyrosine phosphorylation was detectable with a coating density of 0.5 µg/cm2 and the maximum effect was seen with 3 µg/cm2 (Fig. 1B). Plating on fibronectin, collagen IV or laminin did not induce significant tyrosine phosphorylation of SHIP2 (Fig. 2); nor did plating on poly-L-lysine-coated surfaces on which cells adhere in a non-integrin-specific manner. These experiments indicated that tyrosine phosphorylation of SHIP2 modification was stimulated through activation of a subset of integrins that interact with collagen I.



View larger version (53K):
[in this window]
[in a new window]
 
Fig. 1. Collagen I induces SHIP2 tyrosine phosphorylation. Anti-SHIP2 or control pre-immune (Pre) immunoprecipitates (IP) from HeLa cells were blotted with anti-phosphotyrosine ({alpha}-PY). Anti-SHIP2 blots show amounts of SHIP2 protein in respective IP samples. The arrows point to tyrosine-phosphorylated SHIP2. (A) Time course: adherent (Ad), detached (D) or cells that were freshly plated on a collagen-I-coated (6 µg/cm2) surface (C.I) at indicated post-plating intervals were used for IP. (B) Coating density dependency: IPs were carried out as above. Cells were re-plated for 60 minutes on a polystyrene surface coated with increasing concentrations of collagen I (0.1 µg/cm2 to 6 µg/cm2).

 


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2. SHIP2 was not tyrosine phosphorylated when plated on other ECM proteins. IPs and blots were carried out as described in Fig. 1. IPs were from HeLa cells that were adherent (Ad), detached (D) or re-plated (RP) for 60 minutes on surfaces coated with collagen I [6 µg/cm2; C.I, in the presence (+) or absence (-) of 1 µM Src inhibitor PD173956], fibronectin (5 µg/cm2; F), laminin (2 µg/cm2; L), collagen IV (6 µg/cm2; C.IV), or poly-L-lysine (0.01% solution, 0.5 ml/25cm2; P-Ly). Serum-starved adherent cells (Ad) treated with EGF (50 ng/ml for 5 minutes; E) or left untreated (control) are also shown. The arrow points to tyrosine-phosphorylated SHIP2.

 

Src inhibitors block SHIP2 tyrosine phosphorylation
Activation of the cytoplasmic tyrosine kinases, Src and FAK, is an early event during cell attachment to ECM proteins. Several focal adhesion-associated proteins including FAK are substrates of Src and inhibition of Src activation prevents cell adhesion, spreading and migration in several cell types (Cary et al., 1999Go; Jones et al., 2000Go; Parise et al., 2000Go; Schwartz, 2001Go). Therefore, we tested a possible role for Src family kinases in collagen-I-induced SHIP2 tyrosine phosphorylation. To this end, we made use of specific inhibitors of Src family kinases developed in a separate study (Kraker et al., 2000Go). When plated on a collagen-I-coated surface in the presence of three different Src-specific inhibitor compounds, PD173956 (#56), PD173958 (#58) and PD180970 (#70) at 1 µM concentration, tyrosine phosphorylation of SHIP2 was completely blocked (Fig. 2; Fig. 3A). The inhibitory effect of compound PD173956 was seen in a dose-dependent manner starting at 50 nM (Fig. 3B). Similar results were also obtained with PD180970 (data not shown). Collagen-I-specific SHIP2 tyrosine phosphorylation was also observed in SH-SY5Y, a neuroblastoma cell line, and in Madin Darby canine kidney (MDCK) cells. In SY5Y cells, background levels of SHIP2 tyrosine phosphorylation were lower when cells were cultured on plastic but the collagen-I-induced effect was robust (Fig. 4A). In MDCK cells, cells adherent on plastic displayed strong tyrosine phosphorylation of SHIP2, which was decreased upon detachment and restored during attachment on collagen I (Fig. 4B). It was noted that the extent of SHIP2 modification may vary in a cell-type-dependent manner. In both SH-SY5Y and MDCK cell types, collagen-I-dependent tyrosine phosphorylation was completely blocked in the presence of 1 µM Src inhibitor PD173956 (Fig. 4A,B).



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3. Inhibitors of Src family kinases blocked collagen-I-induced SHIP2 tyrosine phosphorylation. (A) IPs were carried out from HeLa cells that were detached (D) or freshly re-plated (RP) on collagen-I-coated dishes (6 µg/cm2) in the presence of vehicle dimethyl sulfoxide (DMSO; —) or Src-kinase-selective Pyrido (2,3-d) pyrimidine tyrosine kinase inhibitors PD173956 (#56), PD173958 (#58) and PD180970 (#70) at 1 µM for 60 minutes. Anti-SHIP2 or pre-immune IPs were immunoblotted with anti-phosphotyrosine ({alpha}-PY) or anti-SHIP2 antibodies. (B) As described above except HeLa cells were re-plated in the presence of DMSO (-) or increasing concentrations (0.05-1.0 µM) of PD173956 (similar results were obtained with PD180970). The arrows point to tyrosine-phosphorylated SHIP2.

 


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 4. Integrin activation caused Src-dependent SHIP2 phosphorylation in other cell types. Anti-SHIP2 or control preimmune (Pre) IPs were blotted with anti-phosphotyrosine ({alpha}-PY) or anti-SHIP2 antibodies. Samples were from cells that were adherent (Ad), detached (D) or freshly re-plated (RP) on collagen-I-coated dishes (6 µg/cm2) in the presence of DMSO (-) or 1 µM Src inhibitor compound PD173956 (+) for 60 minutes. The arrows point to tyrosine-phosphorylated SHIP2. (A) SH-SY5Y neuroblastoma cells. (B) MDCK cells.

 

Src kinases do not mediate EGF- or insulin-mediated tyrosine phosphorylation of SHIP2
In HeLa cells, the Src inhibitors did not alter EGF-induced SHIP2 tyrosine phosphorylation (Fig. 5A). IGF-1 modestly induced SHIP2 tyrosine phosphorylation and the effect of Src inhibitors appeared to be partial. In 3T3-L1 adipocytes, pretreatment with Src inhibitor compounds PD173956 and PD180970 failed to prevent SHIP2 tyrosine phosphorylation from occurring in response to insulin (Fig. 5B).



View larger version (38K):
[in this window]
[in a new window]
 
Fig. 5. Involvement of Src family kinases in collagen I, but not in EGF- or insulin-induced SHIP2 phosphorylation. (A) IPs were carried out from serum-starved HeLa cells that were adherent (Ad), detached (D) or freshly re-plated (RP) on collagen-I-coated dishes (6 µg/cm2) as indicated. Adherent cells were pre-treated with DMSO (-) or Src inhibitor PD173956 at 1 µM (+) for 60 minutes followed by addition of EGF (50 ng/ml for 5 minutes; E) or IGF-1 (25 ng/ml for 10 minutes; I). Adherent samples without any growth factor treatment (Control) are shown as well. Similarly, re-plating of cells was done in the presence of DMSO (-) or 1 µM Src inhibitor PD173956 (+). Anti-SHIP2 or pre-immune IPs were immunoblotted with anti-phosphotyrosine ({alpha}-PY) or anti-SHIP2 antibodies. PD173958 and PD173956 yielded similar results. (B) Anti-SHIP2 IPs from 3T3-L1 adipocytes treated with insulin (50 nM for 15 minutes) or vehicle (V) were blotted with anti-phosphotyrosine ({alpha}-PY). Cells were pre-treated with 1 µM of Src inhibitor compounds, PD173956 (#56) or PD180970 (#70), for 60 minutes prior to insulin treatment. The arrows point to tyrosine-phosphorylated SHIP2.

 

Tyrosines 986-987 are important Src phosphorylation sites
To identify specific tyrosine residues phosphorylated in response to the activation of Src, we examined tyrosine phosphorylation of SHIP2 mutants in which tyrosines conforming to potential phosphorylation site were replaced by phenylalanines. Expression constructs for FLAG-tagged wild-type or SHIP2 mutants were transiently transfected into HeLa cells. Anti-FLAG immunoprecipitates from these cells demonstrated that the YY (986-987) double mutant (YY-FF) in the NPAYY motif was weakly phosphorylated upon re-plating on collagen I. The same effect was seen upon EGF treatment, indicating that the tyrosines 986-987 can also be phosphorylated by a tyrosine kinase unrelated to Src (Fig. 6A). SHIP2 proteins with mutations in three other tyrosines that were potential phosphorylation sites showed little change in tyrosine phosphorylation when compared with wild-type SHIP2 (Fig. 6B). In vitro phosphorylation assays using purified Src kinase indicated that Src could directly phosphorylate SHIP2. These experiments also showed that the 986-987 YY-FF mutation effectively reduced tyrosine phosphorylation of SHIP2 by purified Src kinase (Fig. 6C). While YY 986-987 sites appear to be the major sites for Src phosphorylation, it is also possible that phosphorylation at these sites may be required for the subsequent phosphorylation of SHIP2 at additional sites.



View larger version (43K):
[in this window]
[in a new window]
 
Fig. 6. Tyrosines in the 983NPAYY987 motif are important sites of phosphorylation. (A) Wild-type and YY-FF mutant of FLAG-tagged SHIP2 were transiently expressed in HeLa cells and anti-FLAG immunoprecipitates from adherent control (-), adherent EGF-treated (50 ng/ml for 5 minutes; E), detached (D) or re-plated on collagen I (6 µg/cm2 for 60 minutes; C.I) were blotted with anti-phosphotyrosine ({alpha}-PY) or anti-FLAG (M2) antibodies. (B) Wild-type and three Y-F (497, 747 and 1135) point mutant SHIP2 proteins expressed in HeLa cells were analyzed as above. (C) In vitro phosphorylation reactions were carried out using recombinant Src and immunopurified wild-type or YY-FF mutant SHIP2. Samples were blotted with anti-phosphotyrosine and anti-FLAG (M2) antibodies. The arrows point to tyrosine-phosphorylated SHIP2.

 

Exogenous Src kinase stimulates tyrosine phosphorylation of SHIP2 in vivo
In transient transfection experiments shown in Fig. 7A, a constitutively active form of Src induced strong tyrosine phosphorylation of SHIP2. Conversely, a dominant-negative form of Src kinase reduced collagen-I-induced SHIP2 tyrosine phosphorylation by about 33-50% (Fig. 7C). Three separate experiments consistently produced this effect in experiments where the transfection efficiency was approximately 30-40%.



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 7. Transient transfection studies with exogenous Src corroborate its role in SHIP2 phosphorylation. (A) IPs (anti-SHIP2 and pre-immune) from HeLa cells transiently transfected with expression constructs encoding constitutively active Src (CA-Src) or dominant-negative Src (DN-Src) were blotted with anti-phosphotyroisne ({alpha}-PY). Mock-transfected cells were included as a control. Cells were either adherent on plastic (Ad), detached (D) or freshly re-plated on collagen-I-coated surface (6 µg/cm2) for 60 minutes. The arrow points to tyrosine-phosphorylated SHIP2. The bottom panel shows an anti-SHIP2 blot of the above immunoprecipitate samples. (B) Whole cell lysates prepared from the cells transfected as described above were blotted with anti-Src antibody. (C) Densitometric analyses of SHIP2 tyrosine phosphorylation levels observed in mock-transfected or DN-Src-transfected HeLa cells that were re-plated on a collagen-I-coated surface (6 µg/cm2) for 60 minutes.

 

Cell spreading on collagen I induces SHIP2 association with Shc via the NPXY motif
The NPXY motif serves as an interaction site for the phosphotyrosine-binding (PTB) domain present in signaling proteins. One such PTB-domain-containing protein, Shc, was previously shown to associate with SHIP2 upon stimulation with growth factors (Habib et al., 1998Go). We detected weak phosphotyrosine-containing protein bands co-precipitating with SHIP2 that were migrating similarly to Shc proteins at a molecular mass of ~55 kDa upon cell spreading on collagen I (Fig. 5). We tested whether SHIP2-Shc association was induced during cell adhesion on collagen I. Co-immunoprecipitation experiments revealed induction of specific association between SHIP2 and Shc proteins when detached cells were allowed to spread on collagen I (Fig. 8A). Of the three Shc forms, p52Shc was the more prominent species that co-precipitated with SHIP2. SHIP2-Shc association was detected in both anti-SHIP2 and anti-Shc immunoprecipitations (Fig. 8B,D). The SHIP2-Shc interaction induced by collagen I was sensitive to the Src inhibitor PD180970 at 1 µM concentration (Fig. 8B,D), Moreover, coprecipitation of Shc proteins with SHIP2 occurred only when cells were plated on collagen I but not on fibronectin or poly-L-lysine (Fig. 8B,D). Mutations in the NPAYY motif of SHIP2, YY-FF (986-987), abrogated collagen-I-induced SHIP2-Shc interaction (Fig. 8C). A protein species of approximately 50-55 kDa, corresponding to the heavy chain of immunoglobulins, appeared in all the samples that migrated at the same distance as p52Shc protein.

Phosphorylation of NPAYY motif of SHIP2 regulates lamellipodia formation
We then wished to test the role of tyrosine phosphorylation of SHIP2 in cell spreading. When cells expressing YY-FF (986-987) mutant SHIP2 were allowed to spread on collagen I, marked deregulation of lamellipodia formation was apparent compared with wild-type SHIP2-expressing cells (Fig. 9). Wild-type SHIP2 was distributed to lamellipodia of spreading cells (Fig. 9A) as previously described (Prasad et al., 2001Go). A large number of cells also displayed focal contacts and lamellipodia staining exclusively, with little cytoplasmic staining (not shown). Both untransfected (data not shown) and wild-type SHIP2-expressing cells spread circumferentially in a uniform fashion with broad lamellipodia extensions (Fig. 9B,D). Cells expressing YY-FF (986-987) mutant displayed multiple narrower membrane protrusions with actin spikes at the extremities (Fig. 9C,D). The effect was seen in cells expressing high amounts of YY-FF mutant (brightly stained) and not in cells expressing low levels (lightly stained). On fibronectin, cells expressing wild-type or YY-FF mutant SHIP2 presented a more homogeneous cytoplasmic staining with less intense lamellipodia localization (Fig. 9E,G). In addition, YY-FF mutant did not cause lamellipodia abnormalities (Fig. 9G,H). No overt spreading anomalies were observed in YY-FF mutants expressing cells allowed to spread on laminin as well (data not shown). Taken together, these results indicate a role for Src-mediated tyrosine phosphorylation of SHIP2 in cell spreading and implicate SHIP2 as part of a signaling pathway downstream of Src kinases in adhesion signaling induced by collagen I.



View larger version (56K):
[in this window]
[in a new window]
 
Fig. 9. Expression of YY-FF (986-987) mutant SHIP2 impairs lamelliodia formation. HeLa cells expressing wild-type SHIP2 (A,B,E,F) or YY-FF (986-987; C,D,G,H) mutant proteins were plated on collagen-I-coated (A-D) or fibronectin-coated (E-H) surface for 60 minutes. Cells were stained with anti-FLAG (M2) antibody to reveal expression of exogenous proteins (green) and counterstained with phalloidin-TRITC (red). Bar, 10 µm.

 


    Discussion
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study, we characterize the adhesion-dependent tyrosine phosphorylation of SHIP2 and its role in adhesion and spreading. We show that SHIP2 undergoes tyrosine phosphorylation during attachment and spreading on collagen I but not on fibronectin, collagen IV, laminin or poly-L-lysine. Our experiments indicate that adhesion-dependent SHIP2 tyrosine phosphorylation occurred only in response to signaling from a subset of integrins that interact with collagen I. This is an interesting observation, since the type of collagen as well as the expression pattern of its receptors regulates the behavior of motile cells. For example, integrin {alpha}2ß1, the collagen I receptor expressed predominantly in epithelial cells, activates synthesis of matrix metalloproteinase MMP1 and MMP13 (Ravanti et al., 1999Go; Riikonen et al., 1995Go). Increased expression of collagen receptors {alpha}2ß1 is observed in highly metastatic melanomas (Klein et al., 1991Go). Tyrosine phosphorylation of SHIP2 in response to adhesion to collagen I suggests a potential role for SHIP2 in regulation of cell adhesion and motility.

The results described here indicate for the first time that tyrosine phosphorylation of SHIP2 lies downstream of Src kinases during cell adhesion. In vitro phosphorylation experiments further suggest that SHIP2 could be a direct substrate of Src (Fig. 6C). However, we recognize the fact that purified recombinant kinases could potentially phosphorylate non-physiological substrates under such conditions. It is plausible that SHIP2 may be phosphorylated in vivo by another unrelated tyrosine kinase downstream of activated Src such as c-Abl, FAK or Pyk2 (Cary et al., 1999Go; Plattner et al., 1999Go). Integrin activation may cause recruitment of SHIP2 to focal contacts and lamellipodia through SH2-mediated interaction with phosphorylated p130Cas (Prasad et al., 2001Go), where SHIP2 could be phosphorylated.

Although it is still unclear how tyrosine phosphorylation might regulate SHIP2 activity, proper localization of SHIP2, mediated in part by SH2-mediated interactions, appears to be a pre-requisite for this modification [(Taylor et al., 2000Go) (N.P. and S.J.D., unpublished)]. Tyrosine phosphorylation of SHIP2, may initiate or stabilize its interaction with other yet unidentified signaling molecules. Data presented here support this notion as Src regulates the interaction between SHIP2 and Shc adapter protein mediated through the NPAYY motif of SHIP2. Such interactions may be critical in confining the function of SHIP2 to specific sub-cellular sites. SHIP2 localization to areas where Src and Src-substrates reside further underscores its relevance (Dyson et al., 2001Go; Prasad et al., 2001Go). Interestingly, SHIP2 is constitutively tyrosine phosphorylated and associated with Shc in Rous-sarcoma-virus-transformed fibroblasts and in BCR-ABL-positive chronic myelogenous leukemia (CML) cells (Habib et al., 1998Go; Wisniewski et al., 1999Go). The YY-FF (986-987) SHIP2 mutant displayed deregulation of lamellipodia formation indicating an important role for interactions mediated through this motif in cell spreading. A role for Shc in cell motility and regulation of actin remodeling is well documented (Collins et al., 1999Go; Gu et al., 1999Go; Mauro et al., 1999Go). Therefore, it is possible that disruption of SHIP2-Shc interaction may have significant impact on actin reorganization as shown by irregular membrane protrusions and actin spikes in cells expressing the YY-FF mutant.

Src is a critical component in adhesion signaling. Src kinase localizes to focal adhesions in fibroblasts and to cell-cell junctions in epithelial cells (Fincham et al., 1996Go; Owens et al., 2000Go). Src plays an important role in turnover of focal adhesions and regulates cell motility (Fincham and Frame, 1998Go). In epithelial cells, activated Src induces disassembly of cell-cell adhesions and promotes ECM-dependent invasion (Owens et al., 2000Go). As SHIP2 appears to play an important role in cell adhesion and spreading (Dyson et al., 2001Go; Prasad et al., 2001Go), phosphorylation of SHIP2 regulated by Src kinases represents a molecular mechanism linking activation of tyrosine kinases associated with integrin signaling to phospholipid metabolism. In support of such a notion, some reports suggest that SHIP1 activity could be regulated through tyrosine phosphorylation by Src family kinases following its relocation to cytoskeleton (Gardai et al., 2002Go; Giuriato et al., 2000Go; Lamkin et al., 1997Go).

Recently, SHIP2 was shown to interact with an actin-binding protein filamin and to regulate membranous actin (Dyson et al., 2001Go). Filamin serves as a scaffold for RalA, RhoA, Rac and Cdc42 proteins (Ohta et al., 1999Go). Rho family small GTPases are central regulators of cell adhesion, spreading and migration and are activated by guanine nucleotide exchange factors, GEFs (Ridley, 2001Go). Many GEFs contain phosphoinositol-binding pleckstrin-homology (PH) domains and are consequently regulated by phosphotidylinositol metabolites. SHIP2 upon localization to focal contacts or to lamellipodia, in conjunction with PI 3-kinase, could cause dynamic waves of lipid second messengers, in turn regulating the activation of guanine nucleotide exchange factors for Rho family proteins in a reversible and dynamic fashion. Such dynamic waves of PtdIns metabolites' synthesis and degradation during cell spreading and migration has been demonstrated (Haugh et al., 2000Go). By contrast, SHIP2 activity could also regulate PtdIns(4,5)P2 levels (Taylor et al., 2000Go). PtdIns(4,5)P2, by virtue of its interaction with several actin-binding proteins, plays a critical role in regulation of actin remodeling (Czech, 2000Go; Takenawa and Itoh, 2001Go). Taken together, these studies describe a novel pathway involving Src kinases and SHIP2 in the regulation of cytoskeleton, cell adhesion and motility.


    Acknowledgments
 
We thank Alan J. Kraker (PGRD, Ann Arbor) for Src inhibitor compounds and Roman Herrera (PGRD, Ann Arbor) for helpful discussions. We also greatly appreciate the support and encouragement from Judith Leopold (Cancer Molecular Science, PGRD, Ann Arbor, MI).


    References
 Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

Bachelot, C., Rameh, L., Parsons, T. and Cantley, L. C. (1996). Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts. Biochim. Biophy. Acta 1311,45 -52.[Medline]

Cary, L. A., Han, D. C. and Guan, J. L. (1999). Integrin-mediated signal transduction pathways. Histol. Histopathol. 14,1001 -1009.[Medline]

Clement, S., Krause, U., Desmedt, F., Tanti, J. F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W. et al. (2001). The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409,92 -97.[CrossRef][Medline]

Collins, L. R., Ricketts, W. A., Yeh, L. and Cheresh, D. (1999). Bifurcation of cell migratory and proliferative signaling by the adaptor protein Shc. J. Cell Biol. 147,1561 -1568.[Abstract/Free Full Text]

Corvera, S. and Czech, M. P. (1998). Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction. Trends Cell Biol. 8, 442-446.[CrossRef][Medline]

Czech, M. P. (2000). PIP2 and PIP3: complex roles at the cell surface. Cell 100,603 -606.[Medline]

Di Cristofano, A. and Pandolfi, P. P. (2000). The multiple roles of PTEN in tumor suppression. Cell 100,387 -390.[Medline]

Dyson, J. M., O'Malley, C. J., Becanovic, J., Munday, A. D., Berndt, M. C., Coghill, I. D., Nandurkar, H. H., Ooms, L. M. and Mitchell, C. A. (2001). The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell Biol. 155,1065 -1079.[Abstract/Free Full Text]

Erneux, C., Govaerts, C., Communi, D. and Pesesse, X. (1998). The diversity and possible functions of the inositol polyphosphate 5-phosphatases. Biochim. Biophys. Acta 1436,185 -199.[Medline]

Fincham, V. J. and Frame, M. C. (1998). The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J. 17,81 -92.[Abstract/Free Full Text]

Fincham, V. J., Unlu, M., Brunton, V. G., Pitts, J. D., Wyke, J. A. and Frame, M. C. (1996). Translocation of Src kinase to the cell periphery is mediated by the actin cytoskeleton under the control of the Rho family of small G proteins. J. Cell Biol. 135,1551 -1564.[Abstract]

Fukui, Y. and Hanafusa, H. (1989). Phosphatidylinositol kinase activity associates with viral p60src protein. Mol. Cell. Biol. 9,1651 -1658.[Medline]

Gardai, S., Whitlock, B. B., Helgason, C., Ambruso, D., Fadok, V., Bratton, D. and Henson, P. M. (2002). Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J. Biol. Chem. 277,5236 -5246.[Abstract/Free Full Text]

Giuriato, S., Bodin, S., Erneux, C., Woscholski, R., Plantavid, M., Chap, H. and Payrastre, B. (2000). pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets. Biochem. J. 348,107 -112.[CrossRef][Medline]

Gu, J., Tamura, M., Pankov, R., Danen, E. H., Takino, T., Matsumoto, K. and Yamada, K. M. (1999). Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 146,389 -403.[Abstract/Free Full Text]

Habib, T., Hejna, J. A., Moses, R. E. and Decker, S. J. (1998). Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J. Biol. Chem. 273,18605 -18609.[Abstract/Free Full Text]

Haugh, J. M., Codazzi, F., Teruel, M. and Meyer, T. (2000). Spatial sensing in fibroblasts mediated by 3' phosphoinositides. J. Cell Biol. 151,1269 -1280.[Abstract/Free Full Text]

Ji, P. and Haimovich, B. (1999). Integrin alpha IIb beta 3-mediated pp125FAK phosphorylation and platelet spreading on fibrinogen are regulated by PI 3-kinase. Biochim. Biophys. Acta 1448,543 -552.[Medline]

Jones, R. J., Brunton, V. G. and Frame, M. C. (2000). Adhesion-linked kinases in cancer; emphasis on src, focal adhesion kinase and PI 3-kinase. Eur. J. Cancer 36,1595 -1606.[CrossRef][Medline]

Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. and Downward, J. (1997). Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16,2783 -2793.[Abstract/Free Full Text]

King, W. G., Mattaliano, M. D., Chan, T. O., Tsichlis, P. N. and Brugge, J. S. (1997). Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17,4406 -4418.[Abstract]

Klein, C. E., Dressel, D., Steinmayer, T., Mauch, C., Eckes, B., Krieg, T., Bankert, R. B. and Weber, L. (1991). Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J. Cell Biol. 115,1427 -1436.[Abstract]

Kraker, A. J., Hartl, B. G., Amar, A. M., Barvian, M. R., Showalter, H. D. and Moore, C. W. (2000). Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors. Biochem. Pharmacol. 60,885 -898.[CrossRef][Medline]

Lamkin, T. D., Walk, S. F., Liu, L., Damen, J. E., Krystal, G. and Ravichandran, K. S. (1997). Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J. Biol. Chem. 272,10396 -10401.[Abstract/Free Full Text]

Li, E., Stupack, D. G., Brown, S. L., Klemke, R., Schlaepfer, D. D. and Nemerow, G. R. (2000). Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry. J. Biol. Chem. 275,14729 -14735.[Abstract/Free Full Text]

Majerus, P. W., Kisseleva, M. V. and Norris, F. A. (1999). The role of phosphatases in inositol signaling reactions. J. Biol. Chem. 274,10669 -10672.[Free Full Text]

Mauro, L., Sisci, D., Bartucci, M., Salerno, M., Kim, J., Tam, T., Guvakova, M. A., Ando, S. and Surmacz, E. (1999). SHC-alpha5betal integrin interactions regulate breast cancer cell adhesion and motility. Exp. Cell Res. 252,439 -448.[CrossRef][Medline]

Muraille, E., Pesesse, X., Kuntz, C. and Erneux, C. (1999). Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J. 342,697 -705.[CrossRef][Medline]

Ohta, Y., Suzuki, N., Nakamura, S., Hartwig, J. H. and Stossel, T. P. (1999). The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. USA 96,2122 -2128.[Abstract/Free Full Text]

Owens, D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C. and Brunton, V. G. (2000). The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol. Biol. Cell 11, 51-64.[Abstract/Free Full Text]

Parise, L. V., Lee, J. and Juliano, R. L. (2000). New aspects of integrin signaling in cancer. Semin. Cancer Biol. 10,407 -414.[CrossRef][Medline]

Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A. and Pendergast, A. M. (1999). c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13,2400 -2411.[Abstract/Free Full Text]

Prasad, N., Topping, R. S., Zhou, D. and Decker, S. J. (2000). Oxidative stress and vanadate induce tyrosine phosphorylation of phosphoinositide-dependent kinase 1 (PDK1). Biochemistry 39,6929 -6935.[CrossRef][Medline]

Prasad, N., Topping, R. S. and Decker, S. J. (2001). SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol. Cell. Biol. 21,1416 -1428.[Abstract/Free Full Text]

Ravanti, L., Heino, J., Lopez-Otin, C. and Kahari, V. M. (1999). Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 274,2446 -2455.[Abstract/Free Full Text]

Ridley, A. J. (2001). Rho family proteins: coordinating cell responses. Trends Cell Biol. 11,471 -477.[CrossRef][Medline]

Riikonen, T., Westermarck, J., Koivisto, L., Broberg, A., Kahari, V. M. and Heino, J. (1995). Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J. Biol. Chem. 270,13548 -13552.[Abstract/Free Full Text]

Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y. and Lucas, D. M. (2000). Structure, function, and biology of SHIP proteins. Genes Dev. 14,505 -520.[Free Full Text]

Schwartz, M. A. (2001). Integrin signaling revisited. Trends Cell Biol. 11,466 -470.[CrossRef][Medline]

Takenawa, T. and Itoh, T. (2001). Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim. Biophys. Acta 1533,190 -206.[Medline]

Taylor, V., Wong, M., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. and Stokoe, D. (2000). 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20,6860 -6871.[Abstract/Free Full Text]

Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H. et al. (2001). Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity. Mol. Cell. Biol. 21,1633 -1646.[Abstract/Free Full Text]

Watton, S. J. and Downward, J. (1999). Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9, 43-436.[CrossRef][Medline]

Wisniewski, D., Strife, A., Swendeman, S., Erdjument-Bromage, H., Geromanos, S., Kavanaugh, W. M., Tempst, P. and Clarkson, B. (1999). A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93,2707 -2720.[Abstract/Free Full Text]

Zheng, D. Q., Woodard, A. S., Tallini, G. and Languino, L. R. (2000). Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J. Biol. Chem. 275,24565 -24574.[Abstract/Free Full Text]